CN113117003A - A Chinese medicinal composition for treating hyperosteogeny, and its preparation method - Google Patents

A Chinese medicinal composition for treating hyperosteogeny, and its preparation method Download PDF

Info

Publication number
CN113117003A
CN113117003A CN202110623795.1A CN202110623795A CN113117003A CN 113117003 A CN113117003 A CN 113117003A CN 202110623795 A CN202110623795 A CN 202110623795A CN 113117003 A CN113117003 A CN 113117003A
Authority
CN
China
Prior art keywords
traditional chinese
chinese medicine
preparation
medicine composition
white
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110623795.1A
Other languages
Chinese (zh)
Inventor
李桥生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110623795.1A priority Critical patent/CN113117003A/en
Publication of CN113117003A publication Critical patent/CN113117003A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/758—Zanthoxylum, e.g. pricklyash
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating hyperosteogeny and a preparation method thereof, wherein the traditional Chinese medicine composition comprises the following medicinal components in parts by weight: 2-7 g of Jiuzi Zinian, 10-20 g of garden balsam stem, 11-18 g of milk berry vine, 8-15 g of madder, 10-20 g of radix euphorbiae lantu, 10-20 g of white achyranthes bidentata, 10-20 g of acanthopanax, 3-8 g of radix angelicae and 8-15 g of large elderberry. The preparation method comprises the steps of cleaning the medicinal components, drying in the sun, cutting into small pieces, adding the small pieces into a wine jar, adding white spirit into the wine jar, adding 20-25 kg of the traditional Chinese medicine composition into 100kg of the white spirit according to the proportion of the white spirit to the traditional Chinese medicine composition, finally, sealing and soaking for more than 1 year, and filtering to remove filter residues to obtain filtrate, namely the traditional Chinese medicine preparation. The Chinese medicinal preparation prepared by the invention has the advantages of no need of taking medicine, no need of injection, no need of operation, safe use, low medical expense, good curative effect and quick response.

Description

A Chinese medicinal composition for treating hyperosteogeny, and its preparation method
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a preparation method of a traditional Chinese medicine composition for treating hyperosteogeny.
Background
The diseases such as hyperosteogeny, severe wind, rheumatism, gout and the like are common diseases and frequently encountered diseases, and the diseases bring discomfort to the body and pain to the mind of patients. Hyperosteogeny is a common disease, and can be divided into cervical vertebra hyperplasia, shoulder joint hyperplasia, lumbar vertebra hyperplasia, elbow joint hyperplasia, knee joint hyperplasia, calcaneus hyperplasia and the like according to parts. Hyperosteogeny of each part can cause pathological changes of corresponding parts of a human body, and bring various damages and even great pain to patients. For example, cervical hyperplasia and intervertebral protrusion can cause cervical vision disorder, cervical hearing disorder, cervical coronary heart disease, cervical blood pressure disorder, vertigo, and even dementia caused by brain atrophy due to long-term cerebral blood supply insufficiency; lumbar hyperplasia (intervertebral disc protrusion) can cause pain around waist and waist, when the pain is serious, the pain is radiated to buttocks and inner and outer sides of thighs, sciatica is involved, crus are delayed, lower limbs are numb, and paralysis is even caused; knee joint hyperplasia causes knee joint pain, difficulty in flexion and extension, and difficulty in lifting when people weigh; calcaneus hyperplasia causes heel dare to fall down, walking hard, etc. At present, domestic methods for treating the hyperosteogeny mainly comprise the following steps: the first method is direct current drug iontophoresis, also called physiotherapy: the drug ions mainly enter into the skin through the sweat gland catheter oral pores or enter into mucosal tissues through mucosa and epithelial cell gaps, the physiological treatment effect of the drug ions is mainly determined by the pharmacological property of the introduced drug ions besides the current effect, the direct current drug ion introduction method fully plays the role of the drug, but the introduced drug is liquid and volatilizes, the drug effect is not lasting, and the treatment effect of the method is limited; secondly, ultraviolet therapy: the treatment effect is mainly manifested by sterilization, inflammation diminishing, pain relieving, wound healing promotion, desensitization, formation promotion of vitamin D3, regulation of organism immunity and the like; thirdly, massage and traction: the massage is helpful for improving local blood circulation, and has effects of diminishing inflammation and relieving pain; traction can relieve the pressure of the bony spur on local nerves and tissues to play a role in temporarily relieving pain; is suitable for hyperosteogeny of cervical vertebra and lumbar vertebra, but the massage and traction are completely acted by external force, only the local treatment is carried out, but the integral regulation in the human body is neglected, and only the temporary pain relieving effect can be achieved, but the treatment purpose can not be achieved; fourthly, acupuncture and moxibustion: acupuncture and moxibustion can promote menstruation and blood circulation, has the effect of relieving pain and can eliminate local edema and inflammation, but can only play an auxiliary role in hyperosteogeny; fifthly, western medicine treatment: at present, the western medicine has no effective treatment medicine for the disease, and the treatment for the disease is usually adopted, for example, some antipyretic and analgesic medicines can be taken when pain occurs; the B vitamins can be selected for the numb patients; the joint swelling patient with effusion can be treated by local effusion extraction or local closure, but practice proves that the treatment methods are not ideal, only the symptoms are treated but not the root causes, and the disease is easy to relapse; sixthly, surgical treatment: the operation treatment is not the first choice therapy of the hyperosteogeny, when the conservative treatment is selected to be ineffective, the disease condition is serious and the life of a patient is seriously influenced, the operation treatment can be considered, but the operation treatment cost is high, the harm to the human body is large, and the postoperative hyperplasia can still grow; seventhly, the traditional Chinese medicine is used for treating: because the disease belongs to frequently encountered diseases and common diseases, and western medicines have no ideal treatment method, a large amount of Chinese medicinal herbs are widely applied to treat the disease in recent years, the methods are different, rich and colorful, great progress is achieved, and the defects of single effect, insufficient medicine effect and the like still exist. The traditional Chinese medicine has a history of thousands of years, is a summary of various experiences in the process of struggle between the labor masses and diseases for a long time in China, plays an important role in prosperity and prosperity of Chinese nationalities, and is concerned by people again in the background of rapid development of modern science and technology. Although a plurality of traditional Chinese medicine formulas for treating hyperosteogeny exist on the market, the traditional Chinese medicine formulas have different proportions and different efficacies, and have almost obvious curative effects. Therefore, the invention aims to provide a preparation method of a traditional Chinese medicine composition for treating hyperosteogeny, which has the advantages of reasonable formula, simple preparation, good curative effect, quick response, safety, no side effect and low treatment cost.
Disclosure of Invention
In order to solve the problems in the background art, the invention aims to provide a preparation method of a traditional Chinese medicine composition for treating hyperosteogeny, which has the advantages of reasonable formula, simple preparation, good curative effect, quick response, safety, no side effect and low treatment cost.
The traditional Chinese medicine composition provided by the invention comprises the following medicinal components in parts by weight: 2-7 g of Jiuzi Zinian, 10-20 g of garden balsam stem, 11-18 g of milk berry vine, 8-15 g of madder, 10-20 g of radix euphorbiae lantu, 10-20 g of white achyranthes bidentata, 10-20 g of acanthopanax, 3-8 g of radix angelicae and 8-15 g of large elderberry.
Preferably, the traditional Chinese medicine composition comprises the following medicinal components in parts by weight: 3g of Jiuzi Bull, 15g of garden balsam stem, 12g of milk berry vine, 9g of madder, 15g of radix glehniae, 15g of white achyranthis root, 15g of acanthopanax root, 6g of radix notopterygii and 9g of large elder herb.
The traditional Chinese medicine preparation has scientific and reasonable formula and easily obtained raw materials, and the action mechanism of the medicine components adopted in the invention is as follows:
nine children are not isolated: bitter, slightly pungent and slightly cold in taste; dispelling pathogenic wind, promoting diuresis, dredging collaterals, relieving pain, clearing away heat and toxic materials; mainly wind-damp arthralgia, spasm and numbness, stomach pain, damp-heat jaundice, whitish and turbid urine, stranguria, leucorrhea, traumatic injury, eczema, and venomous snake bite;
garden balsam stem: pungent taste and warm nature; dispelling pathogenic wind and removing dampness, relieving rigidity of muscles and promoting blood circulation, removing blood stasis and detumescence, removing toxic substance and relieving eye pain; mainly rheumatism arthralgia, contracture of muscles and bones, cold-dampness beriberi, waist sprain, paralysis, amenorrhea, eczema of scrotum, sore, furuncle and pyogenic infections;
milk cane: alias: radix Cynanchi Wilfordii, caulis seu radix Schisandrae Henryi, caulis et folium Gaultheriae Yunnanensis, and caulis Erycibes; slightly bitter and astringent taste and mild nature; removing dampness, relieving pain, removing toxic substance, invigorating spleen, resolving food stagnation, and promoting lactation; treating gastralgia, rheumatalgia, traumatic swelling and pain, infantile diarrhea, and lactogenic infection;
madder root: is bitter in taste; cold in nature; cooling blood to stop bleeding, promoting blood circulation and removing blood stasis; governing hemoptysis and hematemesis due to blood heat; epistaxis, hematuria, hematochezia, metrorrhagia, amenorrhea, puerperal abdominal pain due to blood stasis, traumatic injury, rheumatalgia, jaundice, skin ulcer, carbuncle, and hemorrhoid;
blood-breaking: pungent and bitter with warm nature; expelling pathogenic wind and cold, promoting blood circulation, relaxing muscles and tendons, and relieving pain; cough due to pathogenic wind-cold, numbness due to rheumatism, traumatic injury, traumatic hemorrhage, and constipation;
white achyranthes root: radix Cyathulae, radix Achyranthis bidentatae, and radix Achyranthis bidentatae; light taste, bitter taste and mild nature; nourishing liver and kidney, strengthening tendons and bones, relieving dysmenorrhea, dispelling blood stasis, and removing pathogenic wind and dampness; mainly rheumatic arthralgia and myalgia, rheumatic joint pain, postpartum lochiorrhea and damp diseases.
Acanthopanax root: pungent, slightly bitter and warm in nature; replenishing qi to invigorate the spleen, dispelling wind and removing dampness, and dredging channels and collaterals; mainly treating deficiency of spleen-lung qi, asthenia, anorexia, deficiency of both lung and kidney, chronic cough, asthma, kidney deficiency, soreness of waist and knees, heart and spleen deficiency, insomnia, and dreaminess;
a single stator: spicy and bitter taste, moderate in nature; removing rheumatism, relieving pain, stopping bleeding, and removing blood stasis; can be used for treating rheumatalgia, gastralgia, traumatic hemorrhage, and traumatic injury;
big bone-knitting pill: bitter taste and warm nature; setting fracture, dispelling pathogenic wind, activating collaterals, relieving swelling, removing toxic substance, stopping bleeding, and promoting granulation; wind-damp arthralgia, traumatic injury, fracture, carbuncle, furuncle, etc.
In the above-mentioned several Chinese medicinal materials, except for the milk berry vine and white achyranthes root, which are recorded in the medical books, they are local specific medicinal materials, and the other medicinal materials are common medicinal materials, which are recorded in the medical encyclopedia.
The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny is characterized by comprising the following steps:
weighing the following medicinal components in parts by weight: 3-6 g of Jiuzi Bull, 10-20 g of garden balsam stem, 11-18 g of milk berry vine, 8-15 g of madder, 10-20 g of radix euphorbiae lantu, 10-20 g of white achyranthes bidentata, 10-20 g of acanthopanax, 3-8 g of radix angelicae and large elder;
and secondly, respectively cleaning the medicinal components weighed in the step I, airing, cutting into small pieces after airing, adding the cut Chinese medicinal composition into a wine jar, adding white spirit into the wine jar, wherein the ratio of the white spirit to the Chinese medicinal composition is that 20-25 kg of the Chinese medicinal composition is added into 100kg of the white spirit, finally, hermetically soaking the mixture for more than 1 year, and filtering to remove filter residues to obtain filtrate, namely the Chinese medicinal preparation.
In the invention, Chinese liquor is adopted to soak the traditional Chinese medicine components, so that on one hand, the condition that the medicine effect of the traditional Chinese medicine materials is lost due to processing is avoided, and the medicinal components of the traditional Chinese medicine can be retained to the greatest extent; on the other hand, the preparation method is simple, the preparation cost is low, and the preparation can be carried out at home by oneself.
Preferably, in the second step, the white spirit is 60-70 degrees of corn wine, buckwheat wine or sorghum wine.
Further, the using method of the traditional Chinese medicine preparation provided by the invention comprises the steps of filling the traditional Chinese medicine preparation into a spray bottle with a proportional valve, wherein the volume of the spray bottle is 100mL, then spraying the traditional Chinese medicine preparation on the navel of a patient by using the spray bottle, wherein the spraying amount is 0.08-0.1 mL each time, and the spraying is carried out for 3-4 times every day; the ginger decoction is prepared by peeling ginger firstly, beating the ginger to be soft, and adding water to decoct for 15-20 minutes before spraying the traditional Chinese medicine preparation for 15-20 minutes.
Compared with the prior oral administration and the spraying at the pain position, the traditional Chinese medicine preparation prepared by the invention adopts the navel administration, and the mechanism of the administration is as follows: after the fetus comes out, the umbilical cord is cut off and gradually falls off to form an umbilical ring, namely the navel. The concave part has many wrinkled walls, thin epidermis, rare layers and no subcutaneous fat, and is the weakest part of the human body. Based on the special structure of the recess formed by the navel depression, the medicine can be stored for a long time after the navel is administrated, is absorbed more durably, enters a blood circulation and lymphatic system, plays a role in treating the whole body of the medicine, and reduces the damage of the medicine to the liver. The study of Y.chien in the United states shows that the bioavailability of the medicine which is administrated in the original part of the deer gradually is 1-6 times of that of the medicine which is administrated on the forearm. From the physiological anatomy, the umbilicus is the last closed part of the abdominal wall in the embryonic development process, has no subcutaneous fat locally, has the thinnest surface horny layer and weaker barrier function, and is easy to penetrate by drugs; the outer skin is directly connected with the fascia and the peritoneum, the inferior abdominal wall artery is arranged at two sides of the umbilicus, and the umbilical cord is provided with abundant capillary networks, so the medicine is easy to permeate; the natural depression formed by the umbilicus fossa can retain the medicine for a long time, so that the medicine is gradually absorbed and the whole curative effect is exerted. Compared with other external administration methods, the umbilical administration is more beneficial to the absorption of the medicine and has high bioavailability. Because the absorption degree of the compound is far less than that of other administration routes, the compound can avoid the peak-valley phenomenon of the blood concentration and the interference and the action of the gastrointestinal tract environment on the drug effect (such as the influence of gastrointestinal tract enzyme, digestive juice, pH value and other factors) which are caused by oral administration, avoid the first pass effect of the liver, maintain the balanced blood concentration and have no toxic or side effect; and the umbilicus is rich in nerve endings, nerve plexuses and nerve bundles, and is close to the abdominal cavity and the pelvic cavity when seen from the anatomical part. There are major plexuses of autonomic nerves within the abdominal and pelvic cavities that innervate all the organs and blood vessels of the abdominal and pelvic cavities. The medicine is applied to the umbilical region to continuously stimulate the skin of the umbilical region, so that various nerve endings on local skin enter an active state, and the nerve-endocrine-body fluid regulation function is stimulated through nerve reflection and conduction, the functional activity state of various tissues and organs is improved, the disease resistance and the defense capability of a human body are enhanced, and the immunity is improved, so that the purpose of preventing and treating diseases is achieved. The stratum corneum, upon hydration, expands to a porous state, facilitating penetration of the drug. The surfactant or transdermal enhancer in the medicine can promote passive diffusion and absorption, and increase the permeability of epidermal lipid membrane to medicine. In vitro skin test shows that the aromatic medicine can promote the transdermal capacity of the medicine when being applied to local parts. Therefore, by adopting the navel administration, the smell and the drug property of the traditional Chinese medicine preparation can be easily penetrated and absorbed, and the lasting warming effect of the body temperature can better promote the volatilization, dialysis and infiltration of the medicine to reach the action part through microcirculation, thereby achieving the best treatment effect.
Meanwhile, before the traditional Chinese medicine preparation is sprayed, the ginger decoction needs to be drunk firstly, has the effects of sweating and relieving exterior syndrome, can expand pores after being administrated through the navel, and can accelerate the medicine permeation capacity, and on the other hand, the traditional Chinese medicine preparation can possibly generate dryness-heat after entering a human body, and can relieve the symptoms when the dryness-heat is generated.
The invention has the following advantages: the raw materials adopted by the invention are easy to obtain, the preparation method is simpler, the using method is more convenient, and compared with the existing traditional Chinese medicine preparation, the traditional Chinese medicine preparation has the advantages that: the Chinese medicinal composition has the advantages of no need of taking medicine, no need of injection or operation, safe use, low medical cost, good curative effect, quick response and short use period, the curative effect can be seen after the Chinese medicinal composition is used for one month, the Chinese medicinal composition can be used for treating diseases, if the diseases can be treated after the Chinese medicinal composition is used, the Chinese medicinal composition can dredge bones and muscles without diseases, and can strengthen the body without any toxic or side effect; in addition, the traditional Chinese medicine preparation has obvious curative effect on treating hyperosteogeny, and also has wide application range and easy popularization and use for treating various diseases caused by the nervous system disorder, such as cerebral hemorrhage, stroke paralysis, cerebral infarction, numbness of hands and feet, spinal cord injury, rheumatic bone pain, ventilation and other symptoms.
Detailed Description
The present invention is further illustrated by the following examples, which are not intended to be limiting in any way, and any modifications or alterations based on the teachings of the present invention are intended to fall within the scope of the present invention.
Example 1:
the traditional Chinese medicine composition for treating hyperosteogeny is characterized in that: the traditional Chinese medicine composition comprises the following medicinal components in parts by weight: 2g of Jiuzi Bull, 10g of garden balsam stem, 11g of milk berry vine, 8g of madder, 10g of radix glehniae, 10g of white achyranthis root, 10g of acanthopanax root, 3g of radix notopterygii and 8g of large elder herb.
The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny, which is disclosed by the embodiment, is characterized by comprising the following steps:
weighing the following medicinal components in parts by weight: 2g of Jiuzi Bull, 10g of garden balsam stem, 11g of milk berry vine, 8g of madder, 10g of radix glehniae, 10g of white achyranthis bidentatae, 10g of acanthopanax root, 3g of radix paeoniae rubra and 8g of large elderberry;
cleaning the medicinal components weighed in the step I respectively, airing, cutting into small pieces after airing, adding the cut Chinese medicinal composition into a wine jar, adding white wine into the wine jar, wherein the ratio of the white wine to the Chinese medicinal composition is that 20kg of the Chinese medicinal composition is added into 100kg of the white wine, and the white wine is 60-degree grain-wrapped wine, buckwheat wine or sorghum wine, finally, sealing and soaking the mixture for more than 1 year, and filtering to remove filter residues to obtain filtrate, namely the Chinese medicinal preparation.
The using method of the traditional Chinese medicine preparation prepared by the embodiment comprises the steps of filling the traditional Chinese medicine preparation into a spray bottle with a quantitative valve, wherein the volume of the spray bottle is 100mL, and then spraying the traditional Chinese medicine preparation on the navel of a patient, wherein the spraying amount is 0.08mL each time, and the spraying is carried out for 3 times each day. 150mL of ginger decoction is taken 15 minutes before the Chinese medicinal preparation is sprayed. The ginger soup is prepared by peeling ginger, beating, and decocting in water for 15 minutes.
The traditional Chinese medicine preparation prepared in the embodiment 1 has the advantages of no need of taking medicine, no need of injection, no need of operation, safe use, low medical cost, good curative effect and quick response, the navel administration is adopted, the traditional Chinese medicine preparation is sprayed on the Shenque acupoint which is the most sensitive acupoint, after administration, the medicament is conveyed to other channels and collaterals through the Shenque acupoint, and then the medicament is conveyed to the whole body network through the channels and collaterals, so that the optimal special treatment effect is achieved, the traditional Chinese medicine preparation prepared by the invention has a short use period, and the obvious curative effect can be seen after the traditional Chinese medicine preparation is generally used for 1 month.
Example 2:
the traditional Chinese medicine composition for treating hyperosteogeny in the embodiment is composed of the following medicinal components in parts by weight: 3g of Jiuzi Bull, 15g of garden balsam stem, 12g of milk berry vine, 9g of madder, 15g of radix glehniae, 15g of white achyranthis root, 15g of acanthopanax root, 6g of radix notopterygii and 9g of large elder herb.
The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny, which is disclosed by the embodiment, is characterized by comprising the following steps:
weighing the following medicinal components in parts by weight: 3g of Jiuzi Bull, 15g of garden balsam stem, 12g of milk berry vine, 9g of madder, 15g of radix glehniae, 15g of white achyranthis root, 15g of acanthopanax root, 6g of radix paeoniae rubra and 9g of large elder pill;
cleaning the medicinal components weighed in the step I respectively, airing, cutting into small pieces after airing, adding the cut Chinese medicinal composition into a wine jar, adding white wine into the wine jar, wherein the ratio of the white wine to the Chinese medicinal composition is that 23kg of the Chinese medicinal composition is added into 100kg of the white wine, and the white wine is 65-degree grain-wrapped wine, buckwheat wine or sorghum wine, finally, sealing and soaking the mixture for more than 1 year, and filtering to remove filter residues to obtain filtrate, namely the Chinese medicinal preparation.
The using method of the traditional Chinese medicine preparation prepared by the embodiment comprises the steps of filling the traditional Chinese medicine preparation into a spray bottle with a quantitative valve, wherein the volume of the spray bottle is 100mL, and then spraying the traditional Chinese medicine preparation on the navel of a patient, wherein the amount of the traditional Chinese medicine preparation sprayed each time is 0.09mL, and the traditional Chinese medicine preparation is sprayed 3 times a day. 180mL of ginger decoction is taken 18 minutes before the Chinese medicinal preparation is sprayed. The ginger soup is prepared by peeling ginger, beating, adding water and decocting for 18 minutes.
The traditional Chinese medicine preparation prepared in the embodiment 2 has the advantages of no need of taking medicine, no need of injection, no need of operation, safe use, low medical cost, good curative effect and quick response, and the navel administration is adopted, namely the traditional Chinese medicine preparation is sprayed on the Shenque acupoint which is the most sensitive acupoint, after administration, the medicament is conveyed to other channels and collaterals by the Shenque acupoint, and then the medicament is conveyed to the whole body network by the channels and collaterals, so that the optimal special treatment effect is achieved, the traditional Chinese medicine preparation prepared by the invention has a short use period, and the obvious curative effect can be seen after the traditional Chinese medicine preparation is generally used for 1 month.
Example 3:
the traditional Chinese medicine composition for treating hyperosteogeny in the embodiment is composed of the following medicinal components in parts by weight: 7g of Jiuzi Bull, 20g of garden balsam stem, 18g of milk berry vine, 15g of madder, 20g of radix glehniae, 20g of white achyranthis root, 20g of acanthopanax root, 8g of radix paeoniae rubra and 15g of large elder root.
The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny, which is disclosed by the embodiment, is characterized by comprising the following steps:
weighing the following medicinal components in parts by weight: 7g of Jiuzi Bull, 20g of garden balsam stem, 18g of milk berry vine, 15g of madder, 20g of radix euphorbiae lantu, 20g of white achyranthis bidentatae, 20g of acanthopanax, 8g of radix angelicae and 15g of large elder pill;
cleaning the medicinal components weighed in the step I respectively, airing, cutting into small pieces after airing, adding the cut Chinese medicinal composition into a wine jar, adding white wine into the wine jar, wherein the ratio of the white wine to the Chinese medicinal composition is that 25kg of the Chinese medicinal composition is added into 100kg of the white wine, and the white wine is 70-degree grain-wrapped wine, buckwheat wine or sorghum wine, finally, sealing and soaking for more than 1 year, and filtering to remove filter residues to obtain filtrate, namely the Chinese medicinal preparation.
The using method of the traditional Chinese medicine preparation prepared by the embodiment comprises the steps of filling the traditional Chinese medicine preparation into a spray bottle with a quantitative valve, wherein the volume of the spray bottle is 100mL, and then spraying the traditional Chinese medicine preparation on the navel of a patient, wherein the spraying amount is 0.1mL each time, and the spraying is carried out for 4 times each day. 200mL of ginger decoction is taken 20 minutes before the Chinese medicinal preparation is sprayed. The ginger soup is prepared by peeling ginger, beating, adding water and decocting for 20 minutes.
The traditional Chinese medicine preparation prepared in the embodiment 3 has the advantages of no need of taking medicine, no need of injection, no need of operation, safe use, low medical cost, good curative effect and quick response, and the navel administration is adopted, namely the traditional Chinese medicine preparation is sprayed on the Shenque acupoint which is the most sensitive acupoint, after administration, the medicament is conveyed to other channels and collaterals by the Shenque acupoint, and then the medicament is conveyed to the whole body network by the channels and collaterals, so that the optimal special treatment effect is achieved.
Typical case 1: the patient Li (inventor) is a male, is 61 years old when suffering from diseases, is loved and loved locally, is in 6 and 3 months in 2017, is sent to a prefecture county people hospital for examination due to the discovery that the right limbs are flexible and unchangeable, can not speak, feels dizzy, is sour and numb and weak in the whole province, has poor mental general condition, mixed aphasia, crooked left mouth angle, tongue extending right and turbid left eye cornea, and is diagnosed as follows through CT examination: the effect is not ideal after the treatment for cerebral hemorrhage and hospitalization for more than 20 days, then the navel eye is sprayed and treated by the traditional Chinese medicine preparation prepared by the invention, the symptoms are relieved one day after 20 days of use, the symptoms disappear after 45 days of use, the medicine is stopped after 10 days of continuous use, and the situation of relapse does not occur until now.
Typical case 2: a sinus is a female, when the female is in a disease state, the female is 57 years old, the female is loved and loved, the left hand and the left foot are found to be incapable of moving and bouncing in 2018 in 3 months, stroke is diagnosed, the Chinese medicinal preparation prepared by the invention is adopted to carry out navel eye spraying treatment, the left hand can move and bounce after 10 days of use, the left leg can move and bounce after 15 days of use, the left leg can move and bounce after 60 days of use, the female can stand and walk, the medicament is stopped after 10 days of continuous use, and the situation that relapse does not occur until now
Typical case 3: when a woman suffers from the disease, 52 people will be lustered, the waist is sore in 2017 in 4 months, the lower limbs of the person are painful and numb, the person who suffers from the disease goes to be lustered and is examined in a hospital, a doctor diagnoses the hyperosteogeny, the traditional Chinese medicine preparation prepared by the invention is adopted to carry out navel eye spraying treatment, the lumbago is eliminated and the movement is free after 22 days of treatment, the disease is healed after 15 days of continuous taking, and the condition of relapse does not occur until now.
Typical case 4: the disease is characterized in that a male is 42 years old, local people are loved, waist and leg pain of a patient in 2017 months is 4 months, the patient is treated by a hospital in Huizue county, lumbar hyperosteogeny oppresses sciatic nerves, the operation treatment is recommended by the hospital in Huizue people, the operation treatment is abandoned due to difficulty in family conditions, the patient is not convenient to walk and work, the patient has difficulty in self-care in life and day and night, the pain is continuous and hard to endure, the navel eye spraying treatment is carried out by the traditional Chinese medicine preparation prepared by the invention, pain symptoms are obviously improved after 40 days of treatment, the waist can be upright, the patient can be healed after taking the traditional Chinese medicine preparation for 20 days as required, and no relapse exists until now.
In conclusion, the traditional Chinese medicine preparation disclosed by the invention has the advantages that a large number of patients suffering from lumbar vertebra hyperosteogeny are treated in recent years, and the treatment effect is remarkable.

Claims (7)

1. A traditional Chinese medicine composition for treating hyperosteogeny is characterized in that: the traditional Chinese medicine composition comprises the following medicinal components in parts by weight: 2-7 g of Jiuzi Zinian, 10-20 g of garden balsam stem, 11-18 g of milk berry vine, 8-15 g of madder, 10-20 g of radix euphorbiae lantu, 10-20 g of white achyranthes bidentata, 10-20 g of acanthopanax, 3-8 g of radix angelicae and 8-15 g of large elderberry.
2. The traditional Chinese medicine composition for treating hyperosteogeny according to claim 1, wherein: the traditional Chinese medicine composition comprises the following medicinal components in parts by weight: 3g of Jiuzi Bull, 15g of garden balsam stem, 12g of milk berry vine, 9g of madder, 15g of radix glehniae, 15g of white achyranthis root, 15g of acanthopanax root, 6g of radix notopterygii and 9g of large elder herb.
3. The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny according to claim 1, is characterized in that:
weighing the following medicinal components in parts by weight: 3-6 g of Jiuzi Bull, 10-20 g of garden balsam stem, 11-18 g of milk berry vine, 8-15 g of madder, 10-20 g of radix euphorbiae lantu, 10-20 g of white achyranthes bidentata, 10-20 g of acanthopanax, 3-8 g of radix angelicae and large elder;
and secondly, respectively cleaning the medicinal components weighed in the step I, airing, cutting into small pieces after airing, adding the cut Chinese medicinal composition into a wine jar, adding white spirit into the wine jar, wherein the ratio of the white spirit to the Chinese medicinal composition is that 20-25 kg of the Chinese medicinal composition is added into 100kg of the white spirit, finally, hermetically soaking the mixture for more than 1 year, and filtering to remove filter residues to obtain filtrate, namely the Chinese medicinal preparation.
4. The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny according to claim 3, is characterized in that: in the second step, the white spirit is 60-70 degrees of corn wine, buckwheat wine or sorghum wine.
5. The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny according to claim 3, wherein the application method of the traditional Chinese medicine preparation comprises the steps of filling the traditional Chinese medicine preparation into a spray bottle with a quantitative valve, wherein the volume of the spray bottle is 100mL, and spraying the traditional Chinese medicine preparation on the navel eye by using the spray bottle, wherein the spraying amount is 0.08-0.1 mL each time, and the spraying is performed 3-4 times a day.
6. The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny according to claim 5, is characterized in that: 150-200 mL of ginger decoction is taken 15-20 minutes before the Chinese medicinal preparation is sprayed.
7. The preparation method of the traditional Chinese medicine composition for treating hyperosteogeny according to claim 6, is characterized in that: the ginger soup is prepared by peeling ginger and then beating the ginger to be mashed, and adding water to decoct for 15-20 minutes.
CN202110623795.1A 2021-06-04 2021-06-04 A Chinese medicinal composition for treating hyperosteogeny, and its preparation method Pending CN113117003A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110623795.1A CN113117003A (en) 2021-06-04 2021-06-04 A Chinese medicinal composition for treating hyperosteogeny, and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110623795.1A CN113117003A (en) 2021-06-04 2021-06-04 A Chinese medicinal composition for treating hyperosteogeny, and its preparation method

Publications (1)

Publication Number Publication Date
CN113117003A true CN113117003A (en) 2021-07-16

Family

ID=76782865

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110623795.1A Pending CN113117003A (en) 2021-06-04 2021-06-04 A Chinese medicinal composition for treating hyperosteogeny, and its preparation method

Country Status (1)

Country Link
CN (1) CN113117003A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
范虹: "《常见病症药酒良方》", 30 April 2016, 金盾出版社 *

Similar Documents

Publication Publication Date Title
CN101766773B (en) Chinese medicine prescription for treating talagia
CN103463356B (en) The Chinese medicine composition for the treatment of yang deficiency arthromyodynia
CN101791378B (en) Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration
CN104689066A (en) Traditional Chinese medicine composition for treating burns and preparation method thereof
CN101829299A (en) External use paste for preventing and treating prostatosis and preparation method thereof
CN104383384A (en) Traditional Chinese medicine washing liquid for treating tinea of feet and hands
CN103751726A (en) Externally-used traditional Chinese medicine for treating heel pain
CN102949544B (en) Chinese medicinal composition for specifically treating swelling of hands and feet of hemiplegic patients
CN113117003A (en) A Chinese medicinal composition for treating hyperosteogeny, and its preparation method
CN103041085B (en) Traditional Chinese medicine composition for treating dysmenorrheal by lavipeditum nursing and application
CN105561270A (en) Analgesic Chinese herbal medicine for external application and preparation method thereof
CN1313137C (en) Powder for curing pains of muscles and bones
CN104524107A (en) Chinese patent medicine for wind cold damp impediment symptom
CN115006473B (en) Traditional Chinese medicine wine for treating arthralgia and preparation method thereof
CN102406789B (en) Plaster for treating cervical spondylosis
CN108771705B (en) Foot-bath lotion for treating intractable arthralgia as well as preparation method and application thereof
CN105362944A (en) Traditional Chinese medicine ointment for treating orthopedics sprain and contusion
CN105363006A (en) Traditional Chinese medicine ointment for nursing care and treatment of infantile febrile convulsion
CN105853842A (en) Traditional Chinese medicine prescription for treating psoriasis
CN105434594A (en) Traditional Chinese medicine composition which is used for both oral administration and external use, and is used for treating decubitus
CN116898930A (en) Medicinal liquor
CN103948679A (en) External application for treating wind-cold-dampness arthritis
CN108465022A (en) A kind of department of general surgery's trauma operation auxiliary treatment Chinese medicine composition and preparation method thereof
CN114073750A (en) Traditional Chinese medicine formula for treating lumbar sprain, lumbar disc herniation, spinal stenosis and lumbar muscle strain
CN111529606A (en) Medicinal liquor and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210716